Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hiller

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
BMC Psychiatry|September 26, 2018
Suicidal ideation in primary care patients suffering from panic disorder with or without agoraphobiaTobias Teismann, Karoline Lukaschek, Thomas S Hiller, et al.
The Anatomical Record|July 1, 1997
Larynx-associated lymphoid tissue (LALT) in young childrenA Kracke, A S Hiller, T Tschernig, et al.
Cost Effectiveness and Resource Allocation : C/E|May 8, 2019
The allocation of resources in the care for patients with panic disorder in Germany: an excess cost analysis informing policy and scienceChristian Brettschneider, Florian Bleibler, Thomas S Hiller, et al.
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|December 9, 2003
Abnormal serotonergic development in a mouse model for the Smith-Lemli-Opitz syndrome: implications for autismH Waage-Baudet, J M Lauder, D B Dehart, et al.
Nature|May 7, 2015
Cyclic di-GMP acts as a cell cycle oscillator to drive chromosome replicationC Lori, S Ozaki, S Steiner, et al.
Journal of General Internal Medicine|January 23, 2020
Cost-effectiveness of Practice Team-Supported Exposure Training for Panic Disorder and Agoraphobia in Primary Care: a Cluster-Randomized TrialChristian Brettschneider, Jochen Gensichen, Thomas S Hiller, et al.
Scientific Reports|May 11, 2019
Symptom trajectories in patients with panic disorder in a primary care intervention: Results from a randomized controlled trial (PARADISE)Karoline Lukaschek, Thomas S Hiller, Ulrike Schumacher, et al.
Plos One|September 29, 2022
Patient characteristics and changes in anxiety symptoms in patients with panic disorder: Post-hoc analysis of the PARADIES cluster randomised trialTobias Dreischulte, Karoline Lukaschek, Marietta Rottenkolber, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 23, 1998
Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin IIM I Oliverio, H S Kim, M Ito, et al.
Deutsches Arzteblatt International|April 19, 2019
Panic Disorder in Primary CareJochen Gensichen, Thomas S Hiller, Jörg Breitbart, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
BMC Psychiatry|September 26, 2018
Suicidal ideation in primary care patients suffering from panic disorder with or without agoraphobiaTobias Teismann, Karoline Lukaschek, Thomas S Hiller, et al.
The Anatomical Record|July 1, 1997
Larynx-associated lymphoid tissue (LALT) in young childrenA Kracke, A S Hiller, T Tschernig, et al.
Cost Effectiveness and Resource Allocation : C/E|May 8, 2019
The allocation of resources in the care for patients with panic disorder in Germany: an excess cost analysis informing policy and scienceChristian Brettschneider, Florian Bleibler, Thomas S Hiller, et al.
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|December 9, 2003
Abnormal serotonergic development in a mouse model for the Smith-Lemli-Opitz syndrome: implications for autismH Waage-Baudet, J M Lauder, D B Dehart, et al.
Nature|May 7, 2015
Cyclic di-GMP acts as a cell cycle oscillator to drive chromosome replicationC Lori, S Ozaki, S Steiner, et al.
Journal of General Internal Medicine|January 23, 2020
Cost-effectiveness of Practice Team-Supported Exposure Training for Panic Disorder and Agoraphobia in Primary Care: a Cluster-Randomized TrialChristian Brettschneider, Jochen Gensichen, Thomas S Hiller, et al.
Scientific Reports|May 11, 2019
Symptom trajectories in patients with panic disorder in a primary care intervention: Results from a randomized controlled trial (PARADISE)Karoline Lukaschek, Thomas S Hiller, Ulrike Schumacher, et al.
Plos One|September 29, 2022
Patient characteristics and changes in anxiety symptoms in patients with panic disorder: Post-hoc analysis of the PARADIES cluster randomised trialTobias Dreischulte, Karoline Lukaschek, Marietta Rottenkolber, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 23, 1998
Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin IIM I Oliverio, H S Kim, M Ito, et al.
Deutsches Arzteblatt International|April 19, 2019
Panic Disorder in Primary CareJochen Gensichen, Thomas S Hiller, Jörg Breitbart, et al.
Pageof 5